S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
OTCMKTS:KNVKF

Kinnevik (KNVKF) Stock Price, News & Analysis

$37.55
+0.55 (+1.49%)
(As of 06/9/2021)
Today's Range
$37.25
$37.55
50-Day Range
$37.55
$37.55
52-Week Range
$35.24
$56.00
Volume
1,500 shs
Average Volume
1,677 shs
Market Capitalization
$10.33 billion
P/E Ratio
1.74
Dividend Yield
N/A
Price Target
N/A
KNVKF stock logo

About Kinnevik Stock (OTCMKTS:KNVKF)

Kinnevik AB formerly known as Investment AB Kinnevik, is a venture capital firm specializing in investments in growth capital. It prefers to invest in digital consumer business, education, communication, e-commerce and marketplaces, entertainment, healthcare, and financial services but may also invest in other areas. The firm invests worldwide, especially in Europe with a focus on the Nordics, Latin America, Asia, Australia, Africa, and North America. The firm looks for disruptive, technology-enabled and value-added consumer services in developed and emerging markets. It takes an active role on the boards of its subsidiaries and associated companies. It acts as a long-term lead shareholder in large listed entities. Kinnevik AB was founded in 1936 and is based in Stockholm, Sweden.

KNVKF Stock Price History

KNVKF Stock News Headlines

Kinnevik’s Tele2 stake acquired by Freya Investissement
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Kinnevik AB Class B KINV B
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Carbon capture takes off
Kinnevik AB (KINV-B.ST)
Increased Number of Shares and Votes in Kinnevik
See More Headlines
Receive KNVKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kinnevik and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Finance
Industry
Holding Companies
Sub-Industry
N/A
Current Symbol
OTCMKTS:KNVKF
CIK
N/A
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Net Income
$4.39 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$44.24 per share

Miscellaneous

Free Float
N/A
Market Cap
$10.33 billion
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Georgi Ganev (Age 45)
    Chief Exec. Officer
  • Mr. Samuel Kunzli (Age 37)
    Chief Financial Officer
  • Ms. Torun Litzén (Age 54)
    Director of Investor Relations & Corp. Communications
  • Mr. Mattias Andersson (Age 45)
    Gen. Counsel & Company Sec.
  • Ms. Therese Ekström
    Human Resource and Compensation & Benefit Mang.
  • Ms. Anna Stenberg
    Chief People & Platform Officer
  • Mr. Christopher Bischoff (Age 48)
    Sr. Investment Director
  • Mr. Akhil Chainwala (Age 33)
    Investment Director and Venture & Growth Investor
  • Mr. Tim He (Age 38)
    Investment Director & Venture Investor
  • Mr. Andreas Bernstrom (Age 47)
    Sr. Investment Director

KNVKF Stock Analysis - Frequently Asked Questions

How have KNVKF shares performed in 2024?

Kinnevik's stock was trading at $37.55 at the start of the year. Since then, KNVKF stock has increased by 0.0% and is now trading at $37.55.
View the best growth stocks for 2024 here
.

How do I buy shares of Kinnevik?

Shares of KNVKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:KNVKF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners